{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:31:26Z","timestamp":1794083486736,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13311-022-01310-y","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:05:36Z","timestamp":1664535936000},"page":"1976-1991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection"],"prefix":"10.1016","volume":"19","author":[{"given":"Yuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Sotome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Otsuguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Maenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-3866","authenticated-orcid":false,"given":"Ken","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.55782\/ane-2011-1848","article-title":"Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade","volume":"71","author":"Oyinbo","year":"2011","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood-brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-022-01310-y_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fncel.2016.00098","article-title":"Inflammogenesis of Secondary Spinal Cord Injury","volume":"10","author":"Anwar","year":"2016","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1007\/s13311-022-01310-y_bib5","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood-brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"issue":"5","key":"10.1007\/s13311-022-01310-y_bib6","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1007\/s12035-016-9910-6","article-title":"Propitious therapeutic modulators to prevent blood-spinal cord barrier disruption in spinal cord injury","volume":"54","author":"Kumar","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1007\/s13311-022-01310-y_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1208\/s12248-017-0123-3","article-title":"Early to long-term alterations of CNS barriers after traumatic brain injury: considerations for drug development","volume":"19","author":"Rodriguez-Grande","year":"2017","journal-title":"AAPS J"},{"issue":"3","key":"10.1007\/s13311-022-01310-y_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2011.07294.x","article-title":"Gamma-glutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood-brain barrier permeability after experimental brain trauma","volume":"118","author":"Lok","year":"2011","journal-title":"J Neurochem"},{"issue":"13","key":"10.1007\/s13311-022-01310-y_bib10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-009-0382-5","article-title":"Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines","volume":"120","author":"Chakraborty","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/toxsci\/kfp033","article-title":"Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714","volume":"108","author":"Feng","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1007\/s13311-022-01310-y_bib13","article-title":"Immunohistochemical and electron microscopy detections on primary cultures of rat cerebral endothelial cells","author":"Deli","year":"1997","journal-title":"In: Boer AG, Sutanto W (eds) Drug transport across the blood\u2013brain barrier: In vivo and in vitro techniques"},{"issue":"3\u20134","key":"10.1007\/s13311-022-01310-y_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1007\/s13311-022-01310-y_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10571-007-9195-4","article-title":"Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells","volume":"27","author":"Nakagawa","year":"2007","journal-title":"Cell Mol Neurobiol"},{"key":"10.1007\/s13311-022-01310-y_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2014.01.006","article-title":"Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-beta1 signaling","volume":"60","author":"Takeshita","year":"2014","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/bbrc.1997.8051","article-title":"Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system","volume":"244","author":"Hoheisel","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1007\/s13311-022-01310-y_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10571-010-9497-9","article-title":"Pitavastatin strengthens the barrier integrity in primary cultures of rat brain endothelial cells","volume":"30","author":"Morofuji","year":"2010","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"10.1007\/s13311-022-01310-y_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nm.4066","article-title":"Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration","volume":"22","author":"Kadoya","year":"2016","journal-title":"Nat Med"},{"issue":"7806","key":"10.1007\/s13311-022-01310-y_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41586-020-2200-5","article-title":"Injured adult neurons regress to an embryonic transcriptional growth state","volume":"581","author":"Poplawski","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/089771501750055794","article-title":"Characteristics of sustained blood-brain barrier opening and tissue injury in a model for focal trauma in the rat","volume":"18","author":"Preston","year":"2001","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.1007\/s13311-022-01310-y_bib22","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.051626798","article-title":"Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury","volume":"98","author":"Weidner","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01310-y_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-211-35205-2_28","article-title":"A new and simple transection knife for study of neurodegeneration and neuroregeneration in animal model","volume":"99","author":"Park","year":"2006","journal-title":"Acta Neurochir Suppl"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.expneurol.2009.06.012","article-title":"Bilateral cervical contusion spinal cord injury in rats","volume":"220","author":"Anderson","year":"2009","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1007\/s13311-022-01310-y_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"7","key":"10.1007\/s13311-022-01310-y_bib26","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1523\/JNEUROSCI.22-07-02792.2002","article-title":"NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors","volume":"22","author":"Jones","year":"2002","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-022-01310-y_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbr.2015.02.038","article-title":"Evaluation of gait impairment in mice subjected to craniotomy and traumatic brain injury","volume":"286","author":"Sashindranath","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-022-01310-y_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.vascn.2012.04.006","article-title":"Comparison of manual and automated filaments for evaluation of neuropathic pain behavior in rats","volume":"66","author":"Nirogi","year":"2012","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"7","key":"10.1007\/s13311-022-01310-y_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1087057106296498","article-title":"Alternative statistical parameter for high-throughput screening assay quality assessment","volume":"12","author":"Sui","year":"2007","journal-title":"J Biomol Screen"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneumeth.2012.10.001","article-title":"Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier","volume":"212","author":"Daniels","year":"2013","journal-title":"J Neurosci Methods"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1007\/s13311-022-01310-y_bib35","first-page":"376","article-title":"Oxidative stress in neurodegenerative diseases","volume":"7","author":"Chen","year":"2012","journal-title":"Neural Regen Res"},{"issue":"11","key":"10.1007\/s13311-022-01310-y_bib36","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1002\/jps.22674","article-title":"Development of a new permeability assay using low-efflux MDCKII cells","volume":"100","author":"Di","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1007\/s13311-022-01310-y_bib37","article-title":"HTS assay validation","author":"Iversen","year":"2004","journal-title":"In: Sittampalam GS, Grossman A, Brimacombe K, et al., editors. Assay Guidance Manual. Bethesda (MD)"},{"issue":"12","key":"10.1007\/s13311-022-01310-y_bib38","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00415-011-6086-x","article-title":"Cerebrospinal fluid\/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica","volume":"258","author":"Kim","year":"2011","journal-title":"J Neurol"},{"key":"10.1007\/s13311-022-01310-y_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-2094-10-44","article-title":"Traumatic axonal injury in the mouse is accompanied by a dynamic inflammatory response, astroglial reactivity and complex behavioral changes","volume":"10","author":"Ekmark-Lewen","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jor.22727","article-title":"Development of a mouse model of supraspinatus tendon insertion site healing","volume":"33","author":"Bell","year":"2015","journal-title":"J Orthop Res"},{"issue":"11","key":"10.1007\/s13311-022-01310-y_bib41","doi-asserted-by":"crossref","first-page":"e112889","DOI":"10.1371\/journal.pone.0112889","article-title":"Gait analysis in a Mecp2 knockout mouse model of Rett syndrome reveals early-onset and progressive motor deficits","volume":"9","author":"Gadalla","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1007\/s13311-022-01310-y_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"issue":"18 Suppl","key":"10.1007\/s13311-022-01310-y_bib43","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S1359-6446(02)02388-7","article-title":"High-throughput cell analysis using multiplexed array technologies","volume":"7","author":"Beske","year":"2002","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1007\/s13311-022-01310-y_bib44","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3233\/JAD-151179","article-title":"High-throughput screening for identification of blood-brain barrier integrity enhancers: A drug repurposing opportunity to rectify vascular amyloid toxicity","volume":"53","author":"Qosa","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1007\/s13311-022-01310-y_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: An overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front Neurol"},{"issue":"6","key":"10.1007\/s13311-022-01310-y_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","article-title":"Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury","volume":"28","author":"Prakash","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1007\/s13311-022-01310-y_bib47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0963689717714102","article-title":"Traumatic brain injury: Current treatment strategies and fFuture endeavors","volume":"26","author":"Galgano","year":"2017","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1007\/s13311-022-01310-y_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/FJC.0b013e31821076d3","article-title":"Pranlukast attenuates hydrogen peroxide-induced necrosis in endothelial cells by inhibiting oxygen reactive species-mediated collapse of mitochondrial membrane potential","volume":"57","author":"Zhao","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1007\/s13311-022-01310-y_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J Control Release"},{"issue":"9","key":"10.1007\/s13311-022-01310-y_bib50","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.xphs.2017.04.080","article-title":"Routes for drug translocation across the blood-brain barrier: Exploiting peptides as delivery vectors","volume":"106","author":"Kristensen","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1007\/s13311-022-01310-y_bib51","series-title":"The principles of humane experimental technique","author":"Russell","year":"1959"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/jcbfm.2014.199","article-title":"Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia","volume":"35","author":"Krueger","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cne.10736","article-title":"Rats and mice exhibit distinct inflammatory reactions after spinal cord injury","volume":"462","author":"Sroga","year":"2003","journal-title":"J Comp Neurol"},{"issue":"4","key":"10.1007\/s13311-022-01310-y_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jmri.22323","article-title":"Neuropathological differences between rats and mice after spinal cord injury","volume":"32","author":"Byrnes","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"10.1007\/s13311-022-01310-y_bib55","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.5693","article-title":"Berberis vulgaris and berberine: An update review","volume":"30","author":"Imenshahidi","year":"2016","journal-title":"Phytother Res"},{"key":"10.1007\/s13311-022-01310-y_bib56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: An update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1007\/s13311-022-01310-y_bib57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JME-17-0014","article-title":"Berberine reduced blood pressure and improved vasodilation in diabetic rats","volume":"59","author":"Ma","year":"2017","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"10.1007\/s13311-022-01310-y_bib58","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5475","article-title":"A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother Res"},{"issue":"4","key":"10.1007\/s13311-022-01310-y_bib59","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ptr.6282","article-title":"Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials","volume":"33","author":"Fogacci","year":"2019","journal-title":"Phytother Res"},{"key":"10.1007\/s13311-022-01310-y_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2012.03.065","article-title":"Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-kappaB expression, ameliorated BBB permeability","volume":"1459","author":"Zhang","year":"2012","journal-title":"Brain Res"},{"key":"10.1007\/s13311-022-01310-y_bib61","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.2147\/NDT.S114846","article-title":"Role of berberine in Alzheimer's disease","volume":"12","author":"Cai","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1007\/s13311-022-01310-y_bib62","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3892\/ijmm.2014.1656","article-title":"Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease","volume":"33","author":"Kim","year":"2014","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1007\/s13311-022-01310-y_bib63","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.0903853","article-title":"Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine","volume":"185","author":"Qin","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"10.1007\/s13311-022-01310-y_bib64","doi-asserted-by":"crossref","first-page":"e115694","DOI":"10.1371\/journal.pone.0115694","article-title":"Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"issue":"58","key":"10.1007\/s13311-022-01310-y_bib65","doi-asserted-by":"crossref","first-page":"98312","DOI":"10.18632\/oncotarget.21203","article-title":"Berberine attenuated pro-inflammatory factors and protect against neuronal damage via triggering oligodendrocyte autophagy in spinal cord injury","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01310-y_bib67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn3407","article-title":"Animal models of traumatic brain injury","volume":"14","author":"Xiong","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1007\/s13311-022-01310-y_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1470-2045(03)01137-9","article-title":"Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer","volume":"4","author":"Sridhar","year":"2003","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1007\/s13311-022-01310-y_bib69","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00030.2015","article-title":"Expression and function of the epidermal growth factor receptor in physiology and disease","volume":"96","author":"Chen","year":"2016","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1007\/s13311-022-01310-y_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","article-title":"Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia","volume":"36","author":"Baccelli","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01310-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:35:09Z","timestamp":1761806109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1878747923001496"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01310-y","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01310-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}